Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: A population based case-control study

European Journal of Epidemiology

Volumn 28, Issue 11, 2013, Pages 875-887

  Rozendaal, Anna M ^a,b   Van Essen, Anthonie J ^c   Te Meerman, Gerard J ^c   Bakker, Marian K ^c   Van Der Biezen, Jan J ^d   Goorhuis Brouwer, Sieneke M ^c   Vermeij Keers, Christl ^a   De Walle, Hermien E K ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Classification; Cleft lip; Cleft palate; Congenital anomalies; Folic acid; Registry

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ADULT; ARTICLE; ATTRIBUTABLE RISK; BIRTH DEFECT; CLEFT LIP; CLEFT LIP PALATE; CLEFT PALATE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG EXPOSURE; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NETHERLANDS; POPULATION BASED CASE CONTROL STUDY; PRENATAL CARE; RISK ASSESSMENT; TISSUE DIFFERENTIATION; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HUMANS; MALE; MATERNAL AGE; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; POPULATION SURVEILLANCE; PREGNANCY; RISK; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 84890488012     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9849-0     Document Type: Article

References (51)

1. Wehby GL, Murray JC. Folic acid and orofacial clefts: a review of the evidence. Oral Dis. 2010;16(1):11-9.
2. Johnson CY, Little J. Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol. 2008;37(5):1041-58.
3. De-Regil LM, Fernandez-Gaxiola AC, Dowswell T, Pena-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010;10:CD007950.
4. Jugessur A, Farlie PG, Kilpatrick N. The genetics of isolated orofacial clefts: from genotypes to subphenotypes. Oral Dis. 2009;15(7):437-53.
5. Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet. 2009;374(9703):1773-85.
6. Krapels IP, Vermeij-Keers C, Muller M, De Klein A, Steegers-Theunissen RP. Nutrition and genes in the development of orofacial clefting. Nutr Rev. 2006;64(6):280-8.
7. Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet. 2011;12(3):167-78.
8. Luijsterburg AJ, Rozendaal AM, Vermeij-Keers C. Classifying common oral clefts: a new approach after descriptive registration. Cleft Palate Craniofac J. 2013;. doi: 10.1597/12-088.
9. Rozendaal AM, Luijsterburg AJM, Mohangoo AD, Ongkosuwito EM, De Vries E, Vermeij-Keers C. Validation of the Dutch registry of common oral clefts: quality of recording specific oral cleft features. Cleft Palate Craniofac J. 2012;49(5):609-17.
10. Luijsterburg AJM, Vermeij-Keers C. Ten years recording common oral clefts with a new descriptive system. Cleft Palate Craniofac J. 2011;48(2):173-82.
11. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327(26):1832-5.
12. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol. 1998;78(2):151-61.
13. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol. 2004;70(11):853-61.
14. Rozendaal AM, Mohangoo AD, Ongkosuwito EM, Buitendijk SE, Bakker MK, Vermeij-Keers C. Regional variation in prevalence of oral cleft live births in the Netherlands 1997-2007: time-trend analysis of data from three Dutch registries. Am J Med Genet A. 2012;158A(1):66-74.
15. Greenlees R, Neville A, Addor MC, Amar E, Arriola L, Bakker M, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol. 2011;91(1):S51-100.
16. European Surveillance of Congenital Anomalies. EUROCAT guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomalies. 2005. http://www.eurocat-network.eu/content/EUROCAT-Guide- 1.3.pdf. Accessed 26 Mar 2012.
17. Van der Meulen J, Mazzola R, Strickler M, Raphael B. Classification of craniofacial malformations. In: Stricker M, Van der Meulen JC, Raphael B, Mazzola R, Tolhurst DE, Murray JE, editors. Craniofacial malformations. Edinburgh: Churchill Livingstone; 1990. p. 149-309.
18. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343(22):1608-14.
19. Meijer WM, De Walle HEK, Kerstjens-Frederikse WS, De Jong-van den Berg LT. Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reprod Toxicol. 2005;20(2):203-7.
20. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185-93.
21. Baardman ME, Kerstjens-Frederikse WS, Corpeleijn E, de Walle HE, Hofstra RM, Berger RM, et al. Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: evidence for interaction? Heart. 2012;98(6):474-9.
22. Van Beynum IM, Kapusta L, Bakker MK, Den Heijer M, Blom HJ, De Walle HEK. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J. 2010;31(4):464-71.
23. Hartwig NG, Vermeij-Keers C, De Vries HE, Kagie M, Kragt H. Limb body wall malformation complex: an embryologic etiology? Hum Pathol. 1989;20(11):1071-7.
24. Czeizel AE. The primary prevention of birth defects: multivitamins or folic acid? Int J Med Sci. 2004;1(1):50-61.
25. Harville EW, Wilcox AJ, Lie RT, Vindenes H, Abyholm F. Cleft lip and palate versus cleft lip only: are they distinct defects? Am J Epidemiol. 2005;162(5):448-53.
26. Rittler M, Lopez-Camelo JS, Castilla EE, Bermejo E, Cocchi G, Correa A, et al. Preferential associations between oral clefts and other major congenital anomalies. Cleft Palate Craniofac J. 2008;45(5):525-32.
27. Maarse W, Rozendaal AM, Pajkrt E, Vermeij-Keers C, Mink van der Molen AB, Van der Boogaard MJH. A systematic review of associated structural and chromosomal defects in oral clefts: when is prenatal genetic analysis indicated? J Med Genet. 2012;49(8):490-8.
28. Zetstra-van der Woude PA, De Walle HE, De Jong-van den Berg LT. Periconceptional folic acid use: still room to improve. Birth Defects Res A Clin Mol Teratol. 2012;94(2):96-101.
29. Health Council of the Netherlands. Towards an optimal use of folic acid. 2008. http://www.gezondheidsraad.nl/en/publications/towards-optimal-use-folic- acid-0. Accessed 23 Apr 2013.
30. Correa A, Gilboa SM, Botto LD, Moore CA, Hobbs CA, Cleves MA, et al. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol. 2012;206(3):218 e1-e13.
31. Kelly D, O'Dowd T, Reulbach U. Use of folic acid supplements and risk of cleft lip and palate in infants: a population-based cohort study. Br J Gen Pract. 2012;62(600):466-72.
32. Tolarova M. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet. 1982;2(8291):217.
33. Czeizel AE, Timar L, Sarkozi A. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics. 1999;104(6):e66.
34. Li S, Chao A, Li Z, Moore CA, Liu Y, Zhu J, et al. Folic acid use and nonsyndromic orofacial clefts in China: a prospective cohort study. Epidemiology. 2012;23(3):423-32.
35. Little J, Gilmour M, Mossey PA, Fitzpatrick D, Cardy A, Clayton-Smith J, et al. Folate and clefts of the lip and palate - a UK-based case-control study: part II: Biochemical and genetic analysis. Cleft Palate Craniofac J. 2008;45(4):428-38.
36. Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet. 1998;80(3):196-8.
37. Chevrier C, Perret C, Bahuau M, Zhu H, Nelva A, Herman C, et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A. 2007;143(3):248-57.
38. Jugessur A, Wilcox AJ, Lie RT, Murray JC, Taylor JA, Ulvik A, et al. Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads. Am J Epidemiol. 2003;157(12):1083-91.
39. Boyles AL, Ballard JL, Gorman EB, McConnaughey DR, Cabrera RM, Wilcox AJ, et al. Association between inhibited binding of folic acid to folate receptor alpha in maternal serum and folate-related birth defects in Norway. Hum Reprod. 2011;26(8):2232-8.
40. Munger RG, Sauberlich HE, Corcoran C, Nepomuceno B, Daack-Hirsch S, Solon FS. Maternal vitamin B-6 and folate status and risk of oral cleft birth defects in the Philippines. Birth Defects Res A Clin Mol Teratol. 2004;70(7):464-71.
41. Wong WY, Eskes TK, Kuijpers-Jagtman AM, Spauwen PH, Steegers EA, Thomas CM, et al. Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology. 1999;60(5):253-7.
42. Shaw GM, Croen LA, Todoroff K, Tolarova MM. Periconceptional intake of vitamin supplements and risk of multiple congenital anomalies. Am J Med Genet. 2000;93(3):188-93.
43. Yuskiv N, Honein MA, Moore CA. Reported multivitamin consumption and the occurrence of multiple congenital anomalies. Am J Med Genet A. 2005;136(1):1-7.
44. Achon M, Reyes L, Alonso-Aperte E, Ubeda N, Varela-Moreiras G. High dietary folate supplementation affects gestational development and dietary protein utilization in rats. J Nutr. 1999;129(6):1204-8.
45. Pickell L, Brown K, Li D, Wang XL, Deng L, Wu Q, et al. High intake of folic acid disrupts embryonic development in mice. Birth Defects Res A Clin Mol Teratol. 2011;91(1):8-19.
46. Mikael LG, Deng L, Paul L, Selhub J, Rozen R. Moderately high intake of folic acid has a negative impact on mouse embryonic development. Birth Defects Res A Clin Mol Teratol. 2013;97(1):47-52.
47. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr. 2007;86(3):718-27.
48. Yang Q, Cogswell ME, Hamner HC, Carriquiry A, Bailey LB, Pfeiffer CM, et al. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr. 2010;91(1):64-72.
49. Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370-84.
50. Marean A, Graf A, Zhang Y, Niswander L. Folic acid supplementation can adversely affect murine neural tube closure and embryonic survival. Hum Mol Genet. 2011;20(18):3678-83.
51. Haggarty P, Hoad G, Campbell DM, Horgan GW, Piyathilake C, McNeill G. Folate in pregnancy and imprinted gene and repeat element methylation in the offspring. Am J Clin Nutr. 2013;97(1):94-9.